HomeBOLT • NASDAQ
add
Bolt Biotherapeutics Inc
Previous close
$4.44
Day range
$4.19 - $4.64
Year range
$3.91 - $9.66
Market cap
8.91M USD
Avg Volume
28.58K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 2.50M | — |
Operating expense | 3.12M | -21.03% |
Net income | -6.63M | 58.39% |
Net profit margin | -265.24 | — |
Earnings per share | -2.98 | 64.50% |
EBITDA | -5.35M | 64.90% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 27.50M | -41.88% |
Total assets | 56.75M | -43.04% |
Total liabilities | 30.24M | -28.73% |
Total equity | 26.50M | — |
Shares outstanding | 1.92M | — |
Price to book | 0.32 | — |
Return on assets | -23.01% | — |
Return on capital | -26.65% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -6.63M | 58.39% |
Cash from operations | -7.16M | 50.41% |
Cash from investing | 1.07M | -91.22% |
Cash from financing | 5.00K | -82.76% |
Net change in cash | -6.08M | -180.18% |
Free cash flow | -2.92M | 70.71% |
About
Founded
2015
Headquarters
Website
Employees
23
